TDAC
Translational Development Acquisition Corp. Ordinary SharesNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$233.31M
P/E Ratio
36.72
EPS
$0.29
Beta
—
52W High
$10.69
52W Low
$10.15
50-Day MA
$10.58
200-Day MA
$10.45
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Translational Development Acquisition Corp. Ordinary Shares
Trident Acquisitions Corp. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.33% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.30 |
| Price-to-Book | 1.33 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $17.25M |
| Float | $13.49M |
| % Insiders | 0.00% |
| % Institutions | 99.33% |
Historical Volatility
HV 10-Day
4.56%
HV 20-Day
3.49%
HV 30-Day
2.88%
HV 60-Day
2.50%
HV Rank
93.7%
Volatility is currently expanding
Data last updated: 4/29/2026